Literature DB >> 11313381

The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis.

Y Habu1, S Seki, E Takayama, T Ohkawa, Y Koike, K Ami, T Majima, H Hiraide.   

Abstract

NC/Nga (NC) mice raised under conventional conditions (Conv. NC mice) spontaneously develop dermatitis similar to human atopic dermatitis, whereas NC mice raised under the specific pathogen-free conditions do not develop dermatitis. In the present study, we show that the representative Th1 cytokine, IFN-gamma levels in the sera of NC mice, injected with either staphylococcal enterotoxin B or endotoxin (LPS), to be severalfold lower than those of normal mice. The low IFN-gamma response to staphylococcal enterotoxin B was correlated to the lack of regular Vbeta8(+) T cells and Vbeta8(+) NK T cells, and the low IFN-gamma response to LPS was correlated to an impaired IL-18 production of macrophages. The CD3-stimulated IL-4 production from liver and spleen T cells from Conv. NC mice in vitro was greatly augmented. The serum IL-4 levels of untreated Conv. NC mice also were higher than those of normal mice and specific pathogen-free NC mice. Treatment of Conv. NC mice either with IFN-gamma, IL-12, or IL-18 twice a week from 4 wk of age substantially inhibited the elevation of the serum IgE levels, serum IL-4 levels, and dermatitis, and IL-12 or IL-18 treatment also reduced the in vitro IL-4 production from CD3-stimulated liver T cells. The systemic deficiency in the Th1 response to bacterial stimulation thus leads to a Th2-dominant state and may induce an abnormal cellular immune response in the skin accompanied with an overproduction of IgE and a susceptibility to dermatitis in NC mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313381     DOI: 10.4049/jimmunol.166.9.5439

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Lessons from murine models of atopic dermatitis.

Authors:  Tao Zheng; Zhou Zhu
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.806

2.  Multiple interleukin-18 injections promote both mouse Th1 and Th2 responses after sublethal Escherichia coli infection.

Authors:  M Kinoshita; N Kuranaga; A Matsumoto; S Ono; N Shinomiya; H Hiraide; S Seki
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities.

Authors:  Junko Masuda; Eiji Takayama; Warren Strober; Ayano Satoh; Yuji Morimoto; Yasuko Honjo; Tatsuo Ichinohe; Shin-Ichi Tokuno; Toshiaki Ishizuka; Takahiro Nakata; Akifumi Mizutani; Naoki Umemura; Atsushi Kitani; Ivan J Fuss; Tsukasa Shigehiro; Harumi Kawaki; Masako Mizuno-Kamiya; Nobuo Kondoh; Masaharu Seno
Journal:  Oncol Rep       Date:  2017-05-17       Impact factor: 3.906

4.  A defective Th1 response of the spleen in the initial phase may explain why splenectomy helps prevent a Listeria infection.

Authors:  N Kuranaga; M Kinoshita; T Kawabata; N Shinomiya; S Seki
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

5.  Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.

Authors:  Takeshi Yoshioka; Kinichi Imura; Ichiro Hikita; Tsutomu Hirasawa; Tsuneaki Sakata; Takaji Matsutani; Tatsuya Horikawa; Akinori Arimura
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

6.  Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.

Authors:  Yoshiko Habu; Takefumi Uchida; Takuo Inui; Hiroyuki Nakashima; Masashi Fukasawa; Shuhji Seki
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

7.  Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice.

Authors:  Manabu Kinoshita; Shuhji Seki; Satoshi Ono; Nariyoshi Shinomiya; Hoshio Hiraide
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

8.  Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases.

Authors:  M Tachibana; K Wada; K Katayama; Y Kamisaki; K Maeyama; T Kadowaki; R S Blumberg; A Nakajima
Journal:  Allergy       Date:  2008-06-10       Impact factor: 13.146

9.  Simultaneous deficiency in CD28 and STAT6 results in chronic ectoparasite-induced inflammatory skin disease.

Authors:  Qian Liu; Cristin Arseculeratne; Zhugong Liu; Jeannette Whitmire; Michael J Grusby; Fred D Finkelman; Thomas N Darling; Allen W Cheever; James Swearengen; Joseph F Urban; William C Gause
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Role of TRPV3 in immune response to development of dermatitis.

Authors:  Kinichi Imura; Takeshi Yoshioka; Tsutomu Hirasawa; Tsuneaki Sakata
Journal:  J Inflamm (Lond)       Date:  2009-05-25       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.